COMP <GO>
IQV vs UNH // 10Y YIELD & FRED MACRO BETA
IQVIA Holdings Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: IQV 3
— UNH 12
▲ 10Y YIELD & FRED MACRO BETA LEADER: IQV
LAST: $267.33 (-2.81%) • MKT CAP: $45.33B
macro-sensitivity
1.16
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IQV VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IQV | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 88.57% | -47.57 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.40% | 11.47% | -2.07 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.4x | 16.4x | +3.95 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 4.24% | 6.48% | -2.24 | UNH | /fcf-yield <GO> |
| Operating Margin | 13.40% | 4.82% | +8.58 | IQV | /operating-margins <GO> |
| Net Profit Margin | 8.30% | 3.14% | +5.16 | IQV | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | 6.46% | -0.56 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 3.12 | -0.90 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.40% | 6.74% | +0.66 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.0 | 56.0 | -7.05 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.16 | 0.33 | +0.83 | IQV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 17.1x | +13.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.33B | $364.66B | -$319.33B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IQV REV | UNH REV | IQV GROSS % | UNH GROSS % | IQV FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.31B | $447.57B | 44.0% | 88.7% | $1.92B | $16.07B |
| FY 2024 | $15.40B | $400.28B | 44.0% | 88.3% | $2.02B | $20.70B |
| FY 2023 | $14.98B | $371.62B | 44.0% | 89.6% | $1.47B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IQV // BETA 1.16
UNH // BETA 0.33